N. Peng

Ataluren/ivacaftor combination therapy: Two N‐of‐1 trials in cystic fibrosis patients with nonsense mutations

S. Rowe, Jacelyn Emily Peabody Lever, L. Edwards, 2020, Pediatric pulmonology.

Therapeutic benefit observed with the CFTR potentiator, ivacaftor, in a CF patient homozygous for the W1282X CFTR nonsense mutation.

S. Rowe, G. Solomon, D. Hadjiliadis, 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion

R. Green, E. Mendenhall, R. Bostwick, 2021, Nature Communications.

Novel Correctors and Potentiators Enhance Translational Readthrough in CFTR Nonsense Mutations

Ashvani K. Singh, S. Rowe, K. Conrath, 2021, American Journal of Respiratory Cell and Molecular Biology.

Novel Correctors and Potentiators Enhance Functional Rescue of CFTR Nonsense Mutation Translational Readthrough.

Ashvani K. Singh, S. Rowe, K. Conrath, 2021, American journal of respiratory cell and molecular biology.